Nhs

It would be daft for someone to offer you £1.8 billion and you turn it down. That sort of money isn’t to be sniffed at. This is how much Boris Johnson announced he would give to the NHS as an extra funding boost. And I don’t want to seem churlish or ungrateful — after all, those of us who work in the health service are always banging on about how NHS resources are near breaking point. But I have some reservations. The first is the most basic — I’m not sure this is quite the cash windfall it’s made out to be. While Boris has assured us that ‘this is

On the subject of MPs who hope Boris Johnson might give them a job, Matt Hancock was before the Health Select Committee this afternoon, where he ended up taking a fair bit of flak for what the current government hasn’t done, and what the next administration might do. After his own failed leadership bid, the Health and Social Care Secretary backed Johnson, which made for a very awkward section in today’s hearing about the sugar tax. Hancock was repeatedly pressed on Johnson’s pledge to review ‘sin taxes’, including the one on sugary drinks, and he repeatedly answered that the most important thing was to look at the evidence behind the

Last October, Phil Coleman, a journalist on the Carlisle-based News & Star, went to cover the trial of Zholia Alemi, a 56-year-old consultant psychiatrist who was accused of forging the will of an 84-year-old dementia patient in an attempt to inherit her £1.3 million estate. During the trial, Phil realised this complex scam could not have been the work of an amateur fraudster, and suspected previous mischief. How right he was. It turned out that Alemi had been practising in the NHS for 23 years without a medical qualification. Originally from Iran, Alemi moved as a young woman to New Zealand where she claimed she had graduated in medicine from

The benefits of indecision Sir: Belgium has often been without a government for months on end without suffering any economic collapse. In Britain in recent decades governments with large majorities and led by ideologically driven prime ministers have made disastrous decisions on welfare reform, foreign policy and selling off social housing. Isabel Hardman is correct to say that ‘decisions are needed to solve problems that have festered for years’ (‘The in-tray of horrors’, 8 June). However her analysis should also consider the benefits of government paralysis: the damage that has been avoided because superficial and ill-thought-out policies never saw the light of day. Ivor Morgan Lincoln A doctor writes Sir:

Why is it that free trade, which almost everyone agrees is good when conducted with other European countries, suddenly becomes something to be feared when it is proposed with the United States? What is it about American chicken which means that Britons who eat it happily enough when they are on holiday are supposed to fear it when it is imported? And if Americans can offer world-class, well-priced medical services to Britain through the National Health Service, how is that a threat to our social fabric? On his state visit to Britain this week, President Donald Trump reiterated his desire to do a ‘comprehensive’ trade deal with Britain. Given that

For years, Britain has been failing to train enough doctors and has been importing them instead. This has been a well-known and much lamented fact, raising several ethical issues. Is it right for us to rob developing countries of their much-needed medics? Simon Stevens, the head of the NHS, said at the Spectator’s health summit this week that Britain should stop ‘denuding low-income countries of health professionals they need’. Quite so. Which makes it all the more shocking that last year, for the first time ever, the UK imported more doctors than it trained. And the problem Stevens highlights has, under his leadership, been getting steadily worse.  Look at the

Some medical experts claim that Lyme disease is worse than cancer. It’s not a competition, but I do know one thing: at least if you’ve got the Big C you get sympathy, understanding and prompt treatment. With Lyme you’re pretty much on your own. This isn’t a plea for public sympathy. I’ve had Lyme for God knows how long — decades possibly — and though it has disrupted my health and my life in myriad weird, torturous and sometimes hideous ways, I still consider myself one of the fortunate ones. First, it hasn’t killed me; second, I’ve had some state-of-the-art stem cell treatment which with luck will eventually cure me.

‘Gene test for sale on NHS,’ blared the headlines last weekend, sparking some anxiety and confusion. The story is that Genomics England, a company owned by the Department of Health, has announced that it’s seeking people who are willing to pay to have their DNA sequenced. The fee has not yet been specified but it will probably be around £500, depending on how much the analysis is subsidised. Each volunteer will receive a personalised health report and will agree to share their anonymised genetic data with researchers in the hope of improving genetic prediction of diseases and creating the sort of healthcare that’s fit for the future. The story has

Today’s NHS 10-year plan is the health service’s response to the £20.5 billion funding boost announced by ministers last year. The Prime Minister is unveiling further details of the plan this morning, with NHS England chief executive Simon Stevens doing his own broadcast tour to sell it. He argues that the plan ‘tackles head-on the pressures our staff face’ and also ‘sets a practical, costed, phased route map for the NHS’s priorities for care quality and outcomes improvement for the decade ahead’. The plan is a good metaphor for the May government, too: its announcement was delayed from its original launch date of late autumn, there is a £1 billion